Profound Medical (PROF) EBT Margin Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -419.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 110.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -300.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 507.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -287.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 233.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 772.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -464.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 584.00 |
| 10 | Profound Medical | 244.28 Mn | 193.99 Mn | 3.83 Mn | 27,591.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27,591.00 |
| Dec 31, 2025 | -68,952.00 |
| Sep 30, 2025 | 21,291.00 |
| Jun 30, 2025 | -35,366.00 |
| Mar 31, 2025 | 4,724.00 |
| Dec 31, 2024 | 745,163.00 |
| Sep 30, 2024 | -68,240.00 |
| Jun 30, 2024 | -81,023.00 |
| Mar 31, 2024 | -81,467.00 |
| Dec 31, 2023 | -828,567.00 |
| Sep 30, 2023 | 7,707.00 |
| Jun 30, 2023 | 16,488.00 |
| Mar 31, 2023 | -24,016.00 |
| Dec 31, 2022 | 649,704.00 |
| Sep 30, 2022 | 959.00 |
| Jun 30, 2022 | 2,612.00 |
| Mar 31, 2022 | -45,091.00 |
| Dec 31, 2021 | -585,902.00 |
| Sep 30, 2021 | -3,050.00 |
| Jun 30, 2021 | -23,748.00 |
| Mar 31, 2021 | 82,755.00 |
| Dec 31, 2020 | 169,682.00 |
| Sep 30, 2020 | -64,843.00 |
| Jun 30, 2020 | -51,102.00 |
| Mar 31, 2020 | 2,734.00 |